|
Real-time Estimate
Cboe BZX
10:22:31 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 0.4010 USD | +3.86% |
|
+14.42% | -19.22% |
| 09-11 | Cosmos Health Unit Enters 5-Year Contract Manufacturing Deal With Viofar Over Cardiovascular Medicine | MT |
| 09-03 | Cosmos Health Inc. Reaffirms Earnings Guidance for the Year 2026, 2027 and 2029 | CI |
| Market Cap | 38.85M 34.51M 32.27M 29.41M 55.37M 3.74B 56.13M 390M 151M 1.91B 146M 143M 6.12B | P/E 2026 * |
-1.84x | P/E 2027 * | 5.52x |
|---|---|---|---|---|---|
| Enterprise Value | 38.85M 34.51M 32.27M 29.41M 55.37M 3.74B 56.13M 390M 151M 1.91B 146M 143M 6.12B | EV / Sales 2026 * |
0.48x | EV / Sales 2027 * | 0.35x |
| Free-Float |
76.24% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| COSM | Delayed | |
CBOE
| COSM | Real-time | |
|
Tradegate
| V67A | Real-time | |
|
Deutsche Boerse AG
| V67A | Delayed | |
|
Börse Stuttgart
| V67A | Delayed | |
|
Boerse Muenchen
| V67A | Real-time |
| 1 day | -10.19% | ||
| 1 week | +1.58% | ||
| Current month | -10.19% | ||
| 1 month | +69.42% | ||
| 3 months | +91.52% | ||
| 6 months | +21.00% | ||
| Current year | -22.47% |
| 1 week | 0.36 |  | 0.44 |
| 1 month | 0.22 | | 0.48 |
| Current year | 0.16 | | 0.59 |
| 1 year | 0.16 | | 1.32 |
| 3 years | 0.16 | | 1.65 |
| 5 years | 0.16 | | 150 |
| 10 years | 0.16 | | 312.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Grigorios Siokas
CEO | Chief Executive Officer | 60 | 2016-02-25 |
Georgios Terzis
DFI | Director of Finance/CFO | 43 | 2020-11-10 |
| Chief Operating Officer | 56 | 2023-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 58 | 2014-01-12 | |
Grigorios Siokas
CHM | Chairman | 60 | 2016-02-25 |
John Hoidas
BRD | Director/Board Member | 59 | 2016-11-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/30/26 | Buy | Chief Executive Officer | 349,825 | 0.5635% | ||
| 7/29/26 | Free | Chief Financial Officer | 328,407 | 0.5290% | ||
| 7/29/26 | Buy | Chief Executive Officer | 766,284 | 1.2344% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.19% | +1.58% | -64.90% | -75.41% | 38.85M | |
| -0.62% | -2.71% | +39.30% | +114.07% | 1,025B | |
| -2.30% | -4.44% | +39.03% | +66.07% | 623B | |
| -0.63% | -1.96% | +6.36% | +74.38% | 459B | |
| -1.03% | -2.82% | +59.56% | +39.69% | 355B | |
| -0.23% | -3.30% | +22.55% | +40.46% | 336B | |
| -0.46% | -1.79% | +13.11% | +26.01% | 270B | |
| +0.16% | -3.97% | -3.21% | +10.08% | 247B | |
| -3.38% | +0.30% | +36.44% | +51.54% | 220B | |
| -1.04% | -1.46% | +32.70% | +96.82% | 183B | |
| Average | -1.20% | -1.55% | +18.09% | +44.37% | 371.83B | |
| Weighted average by Cap. | +0.14% | -2.11% | +30.39% | +69.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 80.8M 71.77M 67.11M 61.16M 115M 7.78B 117M 812M 314M 3.96B 303M 297M 12.73B | 111M 98.41M 92.03M 83.87M 158M 10.67B 160M 1.11B 431M 5.43B 416M 407M 17.45B |
| Net income | - | - |
| Net Debt | - | - |
Employees
163
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | US$0.4009 | +3.83% | 1,110,889 |
| 26-10-01 | US$0.3861 | -10.19% | 2,467,435 |
| 26-09-30 | US$0.4299 | +2.16% | 3,333,391 |
| 26-09-29 | US$0.4208 | +13.67% | 9,316,294 |
| 26-09-28 | US$0.3702 | +5.29% | 3,538,835 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COSM Stock
Select your edition
All financial news and data tailored to specific country editions
